From the JDD Vault: Case Report on Post-COVID-19 Vaccine Photodistributed Hyperpigmentation Cutaneous reactions and rare dermatologic manifestations linked to COVID-19 vaccination remain a trending topic of discussion among clinicians. In…
Read More
Bridging the Evidence Gap in Skin of Color Hyperpigmentation This is a must-read article from the Journal of Drugs in Dermatology (JDD) that every practicing clinician should have on their…
Read More
From iron oxides to depigmenting agents, how new research is changing tone correction Unlocking clear skin is a constant goal for patients, which is why hyperpigmentation research routinely tops JDD…
Read More
From the Vault: Managing Recurrent Hyperpigmentation Beyond Standard Hydroquinone Regimens Given its complex pathogenesis, chronicity, and high rates of recurrence, melasma remains one of the most challenging conditions in aesthetic…
Read More
Beyond Standard Topicals: Evaluating LTN Serum for Melasma and Acne-Induced PIH Have you caught this compelling clinical update in the recent issue of the JDD? Managing recalcitrant hyperpigmentation disorders such…
Read More
Check Out JDD’s Latest Author Spotlight Our current Author Spotlight features Nada Elbuluk, MD, MSc, FAAD, one of the co-authors of Public Interest in Hyperpigmentation: Insights From a Google Trends…
Read More
Targeted Topical Approaches in Acanthosis Nigricans: Evaluating Sirolimus Gel 0.2% This is a must-read article from the JDD for clinicians treating complex pigmentary and metabolic dermatoses. Acanthosis nigricans remains a…
Read More
This Hyperpigmentation and Melasma Awareness Month, access the peer-reviewed data, treatment guidelines, and clinical pearls your practice needs now As the peak summer sun amplifies patient concerns over dark spots,…
Read More
Search Interest in Hyperpigmentation Is Rising and Dermatology Professionals Should Take Note Have you read this article from the JDD? A new analysis uses Google Trends to shed light on…
Read More
June 25 marks World Vitiligo Day, a global recognition of a condition that affects approximately 0.5-2% of the population worldwide. Though non-life-threatening, vitiligo carries a profound psychosocial burden, disproportionately affecting…
Read More
Topical Metformin versus Kligman’s Formula for Melasma, a Split-Face JDD Study This is a must-read article from JDD a head-to-head split-face study asks whether topical metformin can be an effective,…
Read More
ALA PDT for Facial isSCC Shows Complete Histological Clearance in Early Trial Have you read this article from JDD? A study reports striking short term outcomes after two sessions of…
Read More
